Analeptic Manufacturing India
Levocetirizine (5mg) + Montelukast (10mg)
Limit-LC Tablet is a combination medicine used to treat allergic symptoms such as runny nose, stuffy nose, sneezing, itching, swelling, watery eyes, and congestion or stuffiness.
Tablet
Limit-LC Tablet is a combination medicine used in the treatment of allergic symptoms such as runny nose, stuffy nose, sneezing, itching, swelling, watery eyes, and congestion or stuffiness. It also reduces inflammation in the airways and makes breathing easier.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Limit-LC Tablet may be taken with or without food, but it is better to take it at a fixed time.
No common side effects listed.
Caution is advised when consuming alcohol with Limit-LC Tablet. Please consult your doctor.
Limit-LC Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Limit-LC Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Limit-LC Tablet is a combination of two medicines: Levocetirizine and Montelukast, which relieves sneezing and runny nose due to allergies. Levocetirizine is an antiallergic which blocks a chemical messenger (histamine) responsible for runny nose, watery eyes, and sneezing. Montelukast is a leukotriene antagonist. It works by blocking another chemical messenger (leukotriene). This reduces inflammation (swelling) in the airways and nose and improves symptoms.
You have been prescribed Limit-LC Tablet to help relieve symptoms of allergy such as runny nose, sneezing, watery eyes, and cough. Be cautious while driving or doing anything that requires concentration as Limit-LC Tablet can cause dizziness and sleepiness. Do not drink alcohol while taking Limit-LC Tablet as it may cause increased sleepiness. Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake, and sugarless candy may help. Stop taking Limit-LC Tablet at least three days before taking an allergy test as it can affect the test results.
Limit-LC Tablet contains two active ingredients: Montelukast and Levocetirizine. Levocetirizine is an antihistamine that relieves allergy symptoms such as runny nose, sneezing, watery eyes, and coughing by lowering chemicals in the body responsible for these reactions. Montelukast works by blocking leukotrienes, chemical messengers associated with inflammation (swelling) in the airways and nose. This helps relieve the symptoms further.
Yes, drowsiness is a common side effect of Limit-LC Tablet. Do not drive, operate heavy machinery, or engage in other activities that require your full attention until your doctor has deemed it safe to do so. Avoid alcohol consumption and other central nervous system depressants like cough and cold medications. Additionally, avoid taking certain pain relief medicines and sleep aids as these can amplify drowsiness and increase the risk of falls or accidents.
No, you should continue taking Limit-LC Tablet as advised by your doctor. If you experience any side effects or your symptoms worsen, consult your doctor for re-evaluation.
Yes, Limit-LC Tablet can cause dry mouth. To alleviate this, drink plenty of water throughout the day and keep a glass of water by your bed at night. You may also use lip balm if your lips are also dry.
No, do not consume alcohol while taking Limit-LC Tablet. Alcohol will worsen the drowsiness and sleepiness caused by this medication.
No, increasing the dose of Limit-LC Tablet will not improve its effectiveness. Consuming a higher than recommended dose can increase side effects and may lead to adverse reactions. If your symptoms are worsening, consult with your doctor for re-evaluation.
Keep the medicine in its original container or packaging, tightly closed. Store it according to the directions provided on the packaging label. Do not use expired medication. Ensure that pets, children, and other individuals do not access this medication.